Summit Therapeutics (SMMT) EBIT Margin (QoQ) (2017 - 2022)
Summit Therapeutics (SMMT) EBIT Margin (QoQ) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -229,915.00 |
| Jun 30, 2022 | 346,235.00 |
| Mar 31, 2022 | 151,409.00 |
| Dec 31, 2021 | -888,867.00 |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | -3.28 Mn |
| Mar 31, 2021 | -256,758.00 |
| Dec 31, 2020 | 311,318.00 |
| Sep 30, 2020 | -32,673.00 |
| Jun 30, 2020 | -262,322.00 |
| Mar 31, 2020 | -648,611.00 |
| Dec 31, 2019 | 425,882.00 |
| Oct 31, 2019 | -239,529.00 |
| Oct 31, 2018 | -331,052.00 |
| Jul 31, 2018 | 55,128.00 |
| Apr 30, 2018 | 25,535.00 |
| Jan 31, 2018 | -23,026.00 |
| Oct 31, 2017 | -27,145.00 |
| Jul 31, 2017 | 48,148.00 |